Defining the landscape of HIV-specific T-cell responses in HIV-1 infected durably suppressed participants

Defining the landscape of HIV-specific T-cell responses in HIV-1 infected durably suppressed participants

Bibliographic Details
Main Authors:	J. Warren, S. Zhou, Y. Xu, I. Trumble, K. Mollen, J.M. Sung, J. Kirchherr, A. Adimora, S. Deeks, J. Kuruc, C. Gay, D. Margolis, N. Archin, R. Swanstrom, N. Goonetilleke
Format:	Article
Language:	English
Published:	Elsevier 2017-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020306397

Similar Items

HIV-1 in the latent reservoir is largely sensitive to circulating T cells
by: J. Warren, et al.
Published: (2019-12-01)

Induction of HIV from latency by a novel molecule
by: N.M. Archin, et al.
Published: (2015-12-01)

HIV-Specific T Cell Responses Are Highly Stable on Antiretroviral Therapy
by: Yinyan Xu, et al.
Published: (2019-12-01)

Differential effects of HIV latency-reversing agents on T cell phenotype and function: implications for HIV cure
by: G. Clutton, et al.
Published: (2015-12-01)

CD8 T cells from HIV positive individuals on ART have a skewed differentiation phenotype and impaired proliferative responses
by: G. Clutton, et al.
Published: (2017-12-01)

The HIV-1 latent reservoir is largely sensitive to circulating T cells
by: Joanna A Warren, et al.
Published: (2020-10-01)

The impact of vorinostat and AGS-004, a dendritic cell-based immunotherapy, on persistent HIV-1 Infection
by: C. Gay, et al.
Published: (2019-07-01)

Measuring the Inducible, Replication-Competent HIV Reservoir Using an Ultra-Sensitive p24 Readout, the Digital ELISA Viral Outgrowth Assay
by: Erin L. Stuelke, et al.
Published: (2020-08-01)

Adoptive T cell as a strategy for targeted delivery of immune checkpoint therapy
by: J. Sung, et al.
Published: (2017-12-01)

Vorinostat Renders the Replication-Competent Latent Reservoir of Human Immunodeficiency Virus (HIV) Vulnerable to Clearance by CD8 T Cells
by: Julia A. Sung, et al.
Published: (2017-09-01)

A modified viral outgrowth assay incorporating ultra-sensitive P24 measurements
by: N. Archin, et al.
Published: (2017-12-01)

Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure
by: Nilu Goonetilleke, et al.
Published: (2019-08-01)

Reliable Estimation of CD8 T Cell Inhibition of In Vitro HIV-1 Replication
by: Yinyan Xu, et al.
Published: (2021-06-01)

24 HIV-specific, ex vivo expanded T cell therapy (HXTC) for HIV clearance: feasibility, safety and efficacy
by: Julia M. Sung, et al.
Published: (2017-07-01)

New Frontiers in Measuring and Characterizing the HIV Reservoir
by: Shane D. Falcinelli, et al.
Published: (2019-12-01)

Mechanisms of HIV Suppression by Various Microbes in Human Lymphoid Tissue
by: Margolis Leonid
Published: (2005-12-01)

P20-17. Evolution of multiple transmitted viruses during the early stage of HIV-1 infection
by: McMichael A, et al.
Published: (2009-10-01)

Harnessing CD8+ T Cells Under HIV Antiretroviral Therapy
by: Joanna A. Warren, et al.
Published: (2019-02-01)

Durable Suppression of HIV-1 after Virologic Monitoring-Based Antiretroviral Adherence Counseling in Rakai, Uganda.
by: Alexander Billioux, et al.
Published: (2015-01-01)

Research on HIV cure: Mapping the ethics landscape.
by: Karine Dubé, et al.
Published: (2017-12-01)

Single-cell phenotyping of HIV-infected expanded clones in ART-suppressed individuals
by: C. Dufour, et al.
Published: (2019-12-01)

No evidence for ongoing HIV replication in lymph nodes during suppressive ART
by: W.R. McManus, et al.
Published: (2017-12-01)

Ongoing HIV Transmission and the HIV Care Continuum in North Carolina.
by: Anna B Cope, et al.
Published: (2015-01-01)

Intensification of ART with ABX464 decreases the total HIV reservoir and HIV transcription initiation in CD4 T cells from HIV-infected ART-suppressed individuals
by: S. Moron-Lopez, et al.
Published: (2019-12-01)

Attacking latent HIV: towards eradication of HIV infection
by: Margolis DM
Published: (2006-12-01)

The HIV-1 protective -35SNP effect in Caucasians is CD8 T cell mediated
by: Corrah T, et al.
Published: (2012-09-01)

Dual-affinity re-targeting (DART) proteins overcome viral diversity to deplete the latent HIV-1 reservoir
by: J.M. Sung, et al.
Published: (2015-12-01)

Women and HIV in the United States.
by: Alexander Breskin, et al.
Published: (2017-01-01)

HIV-1: To Splice or Not to Splice, That Is the Question
by: Ann Emery, et al.
Published: (2021-01-01)

Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection.
by: Natalia Soriano-Sarabia, et al.
Published: (2015-10-01)

HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral Suppression
by: Kai Kammers, et al.
Published: (2021-08-01)

ushr: Understanding suppression of HIV in R
by: Sinead E Morris, et al.
Published: (2020-02-01)

Annual and durable HIV retention in care and viral suppression among patients of Peter Ho Clinic, 2013-2017.
by: Debbie Y Mohammed, et al.
Published: (2020-01-01)

The long term durability of combination antiretroviral therapy in HIV-positive patients across Europe
by: Reekie, J. M.
Published: (2012)

Defining rights-based indicators for HIV epidemic transition.
by: Joseph J Amon, et al.
Published: (2018-12-01)

Defining the nature of protective CD8+ T-cell response in lymph nodes of HIV elite controllers
by: M. Betts, et al.
Published: (2017-12-01)

Amplified HIV Transmission: The Missing Link in the HIV Pandemic?
by: Eron JJ, et al.
Published: (2005-12-01)

HIV Trends: Defining “The Middle East”
by: Stephen A. Berger
Published: (2016-07-01)

Chemokines, lymphocytes, and HIV
by: Farber J.M.
Published: (1998-01-01)

Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.
by: Julian H Elliott, et al.
Published: (2014-10-01)